Help us shape the future of the Legislature website!
We are redesigning our website and want your feedback. We are looking for volunteers to participate in research, and some opportunities may be paid. Sign up to participate here!
Bill Information > HB 2363
Search for another bill or initiative:
HB 2363 - 2015-16
Concerning pharmaceutical drug cost and utilization transparency.
Bill History
2016 REGULAR SESSION
Jan 8
Prefiled for introduction.
Jan 11
First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
(View Original Bill)
Jan 19
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
(Committee Materials)
Jan 27
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee Materials)
Jan 29
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 10:00 AM.
(Committee Materials)
2016 1ST SPECIAL SESSION
Mar 10
By resolution, reintroduced and retained in present status.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos
